Tag: pharmaceutical companies corruption
The Latest “Breakthrough Therapy”: Expensive New Drugs for Tardive Dyskinesia
The increased prescribing of antipsychotics, which frequently cause a brain injury that manifests as tardive dyskinesia, has provided pharmaceutical companies with a lucrative new market opportunity.
Professional Mental Health Leaders: Experts in Humanity or in Marketing?
A lot of people, perhaps especially Americans, like a quick fix. Unfortunately, for those of us who get the “help” of the mental health system, the results can be disastrous.
After-the-fact Pharma Payments to FDA Advisers Spark Ethical Concerns
From Science: "Brilinta fits a pattern of what might be called pay-later conflicts of interest, which have gone largely unnoticed—and entirely unpoliced. In examining...
Lansley Joins Roche in Latest Example of ‘Revolving Door’
The BMJ reports that renewed concerns about the “revolving door” between government and industry have been sparked by the health minister of England’s decision to join to drug company Roche.